Emerging New Cannabinoids: THCP, THCV, HHC and More in 2026
What strains are bringing new beyond THC and CBD – varieties rich in rare cannabinoids
The cannabis universe is constantly evolving. While THC (delta-9-tetrahydrocannabinol) and CBD (cannabidiol) have dominated discussions for decades, 2026 marks a turning point with the rise of minor and emerging cannabinoids. Compounds like THCP, THCV, HHC and others are gaining prominence in research, cultivation and regulated markets, driven by advances in breeding, extraction and understanding of the endocannabinoid system.
Understanding Cannabinoids: From Basic to Advanced
Cannabinoids are chemical compounds produced by the Cannabis sativa plant that interact with CB1 and CB2 receptors in the human body. THC is primarily responsible for psychoactive effects, while CBD is non-intoxicating and associated with anti-inflammatory and anxiolytic properties. However, the plant produces over 100 cannabinoids, many in trace amounts, which are now being isolated, synthesized or concentrated through selective breeding.
In 2026, the focus is on “minor cannabinoids” and semi-synthetic derivatives. Legislation varies globally, with intense debates about safety, laboratory testing and regulation.
THCP: The Potent Giant
THCP (tetrahydrocannabiphorol) was identified in 2019. Its structure has a longer side chain, allowing up to 30 times stronger binding to CB1 receptors. This results in much more intense psychoactive effects, even at low doses.
Studies indicate potential for pain relief, improved sleep and appetite. Naturally rare, THCP appears in traces, but selective breeding and extraction are making it more accessible in flowers, vapes and edibles.
THCV: The “Diet Weed” for Energy and Focus
THCV (tetrahydrocannabivarin) acts as a partial CB1 antagonist at low doses, generating stimulating effects, appetite suppression and metabolic benefits. African strains like Durban Poison are naturally rich in THCV. In 2026, varieties such as Doug’s Varin and modern hybrids are being optimized for up to 5% THCV.
HHC: Stability and Smooth Effects
HHC (hexahydrocannabinol) is obtained by hydrogenation of THC or CBD. It offers balanced relaxation, with greater chemical stability and lower risk of paranoia. Despite restrictions in some countries, it remains popular in the hemp-derived market.
Other Emerging Cannabinoids in 2026
- CBG – The precursor of THC and CBD, with strong anti-inflammatory and neuroprotective potential.
- CBN – Oxidized derivative, excellent for sleep.
- CBC – Promoter of neurogenesis and anti-inflammatory.
- THCA, Delta-8, Delta-10 and new ones like THCJD – Experimental variants with unique profiles.
The Role of Strains: Varieties Rich in Rare Cannabinoids
Breeders are focusing on chemovars with high levels of minor cannabinoids. Advances in genomics allow the creation of strains with personalized profiles, expanding the “entourage effect” between cannabinoids and terpenes.
3 Products from Seeds Genetics Co that Stand Out
1. Apple Fritter Feminized
Balanced hybrid (Sour Apple x Animal Cookies) with THC 22-28%+ and terpenes rich in caryophyllene, limonene and pinene. Ideal for expanded entourage with THCP and THCV. Produces dense and resinous buds, perfect for growers who want to explore relaxing and therapeutic effects beyond standard THC.
2. Banana Sherbet Feminized
Cross between Banana Kush and Sunset Sherbet, with a creamy and fruity profile. Its terpenes complement energizing effects similar to THCV. Excellent platform for breeding aiming at rare cannabinoids and tropical flavors.
3. Zkittlez Feminized
Indica-dominant with candy-like aroma. Its terpene spectrum rich in caryophyllene and humulene enhances synergy with HHC, THCP and other minor cannabinoids. A great affordable option from Seeds Genetics Co for those who want to experience complex and innovative varieties.
Challenges, Safety and the Future
Despite the enthusiasm, long-term clinical studies are still lacking. It is essential to prioritize laboratory testing, responsible consumption and respect for local regulations. The future of cannabis points toward personalization, sustainability and functional products based on complete cannabinoid profiles.
Conclusion: In 2026, THCP, THCV, HHC and other cannabinoids are redefining the market. Strains rich in rare compounds, such as those offered by Seeds Genetics Co, allow growers and consumers to explore more nuanced and therapeutic experiences beyond traditional THC and CBD.